标题
Aptamers: Cutting edge of cancer therapies
作者
关键词
aptamer, cancer, RNA therapeutics, immunity, delivery, brain tumors, cancer stem cells
出版物
MOLECULAR THERAPY
Volume 29, Issue 8, Pages 2396-2411
出版商
Elsevier BV
发表日期
2021-06-17
DOI
10.1016/j.ymthe.2021.06.010
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Stoichiometry of multi-specific immune checkpoint RNA antibodies for T-cell activation and tumor inhibition using ultra-stable RNA nanoparticles
- (2021) Dan Shu et al. Molecular Therapy-Nucleic Acids
- Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor Activity
- (2021) Paola Amero et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Enhanced in Vivo Blood–Brain Barrier Penetration by Circular Tau–Transferrin Receptor Bifunctional Aptamer for Tauopathy Therapy
- (2020) Xiaowei Li et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Bifunctional Aptamer–Doxorubicin Conjugate Crosses the Blood–Brain Barrier and Selectively Delivers Its Payload to Epithelial Cell Adhesion Molecule-Positive Tumor Cells
- (2020) Joanna Macdonald et al. Nucleic Acid Therapeutics
- Targeting Ephrin Receptor Tyrosine kinase A2 with a selective aptamer for glioblastoma stem cells
- (2020) Alessandra Affinito et al. Molecular Therapy-Nucleic Acids
- Sgc8-c Aptamer as a Potential Theranostic Agent for Hemato-Oncological Malignancies
- (2020) Estefanía Sicco et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- One nanometer self-assembled aptamer-DNA dendrimers carry 350 doxorubicin: Super-stability and intra-nuclear DNA comet tail
- (2020) Jingqing Le et al. CHEMICAL ENGINEERING JOURNAL
- Dendrimer grafted persistent luminescent nanoplatform for aptamer guided tumor imaging and acid-responsive drug delivery
- (2020) Hong-Jiao Zhang et al. TALANTA
- Vaccination against non-mutated neoantigens induced in recurrent and future tumors
- (2020) Greta Garrido et al. Cancer Immunology Research
- Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3
- (2020) Carla Lucia Esposito et al. Cancers
- Aptamers against mouse and human tumor-infiltrating myeloid cells as reagents for targeted chemotherapy
- (2020) Adriana De La Fuente et al. Science Translational Medicine
- The Role of RNA and DNA Aptamers in Glioblastoma Diagnosis and Therapy: A Systematic Review of the Literature
- (2020) Silvia Nuzzo et al. Cancers
- Non-Invasive Delivery of Therapeutics into the Brain: The Potential of Aptamers for Targeted Delivery
- (2020) Bakhtiar Bukari et al. Biomedicines
- Recognition of nucleolin through interaction with RNA G-quadruplex
- (2020) Tiago Santos et al. BIOCHEMICAL PHARMACOLOGY
- Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology
- (2020) Paola Amero et al. Cancers
- Personalized immunoglobulin aptamers for detection of multiple myeloma minimal residual disease in serum
- (2020) Claudia Tapia-Alveal et al. Communications Biology
- An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells
- (2020) Gang Zhou et al. CANCER LETTERS
- The Clinical Trial Landscape for Melanoma Therapies
- (2019) Sonia Wróbel et al. Journal of Clinical Medicine
- ICOS costimulation at the tumor site in combination with CTLA-4 blockade therapy elicits strong tumor immunity
- (2019) Mario Martínez Soldevilla et al. MOLECULAR THERAPY
- Moving Myeloid Leukemia Drug Discovery Into the Third Dimension
- (2019) Donna M. Cartledge Wolf et al. Frontiers in Pediatrics
- A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer
- (2019) Xin Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Robust gene expression control in human cells with a novel universal TetR aptamer splicing module
- (2019) Adam A Mol et al. NUCLEIC ACIDS RESEARCH
- Endocytic Pathways and Intracellular Transport of Aptamer-Drug Conjugates in Live Cells Monitored by Single-Particle Tracking
- (2019) Cheng Lv et al. ANALYTICAL CHEMISTRY
- Therapeutic applications of AS1411 aptamer, an update review
- (2019) Rezvan Yazdian-Robati et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Anything You Can Do, I Can Do Better: Can Aptamers Replace Antibodies in Clinical Diagnostic Applications?
- (2019) Michelle Bauer et al. MOLECULES
- Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity
- (2019) Greta Garrido et al. Nature Communications
- The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells
- (2019) Alessandra Affinito et al. Molecular Therapy-Nucleic Acids
- Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC
- (2019) Sorah Yoon et al. Molecular Therapy-Nucleic Acids
- A Novel Aptamer LL4A Specifically Targets Vemurafenib-Resistant Melanoma through Binding to the CD63 Protein
- (2019) Hui Li et al. Molecular Therapy-Nucleic Acids
- Aptamers: Uptake mechanisms and intracellular applications
- (2018) Sorah Yoon et al. ADVANCED DRUG DELIVERY REVIEWS
- Challenging cancer targets for aptamer delivery
- (2018) Vittorio de Franciscis BIOCHIMIE
- Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model
- (2018) Walhan Alshaer et al. JOURNAL OF CONTROLLED RELEASE
- Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
- (2018) S. Haubner et al. LEUKEMIA
- Application of the Open qPCR Instrument for the in Vitro Selection of DNA Aptamers against Epidermal Growth Factor Receptor and Drosophila C Virus
- (2018) Tulsi Ram Damase et al. ACS Combinatorial Science
- Aptamers in the Therapeutics and Diagnostics Pipelines
- (2018) Harleen Kaur et al. Theranostics
- STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
- (2018) Carla Lucia Esposito et al. Molecular Therapy-Nucleic Acids
- Estimation of The Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology
- (2018) John Marquart et al. JAMA Oncology
- EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
- (2018) Joanna Macdonald et al. Cancers
- In Vivo Use of a Multi-DNA Aptamer-Based Payload/Targeting System To Study Dopamine Dysregulation in the Central Nervous System
- (2018) Erin M. McConnell et al. ACS Chemical Neuroscience
- Aptamer-guided nanomedicines for anticancer drug delivery
- (2018) Walhan Alshaer et al. ADVANCED DRUG DELIVERY REVIEWS
- Identification of non-mutated neoantigens presented by TAP-deficient tumors
- (2018) Koen A. Marijt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cytosolic Processing Governs TAP-Independent Presentation of a Critical Melanoma Antigen
- (2018) Nathalie Vigneron et al. JOURNAL OF IMMUNOLOGY
- An RNA toolbox for cancer immunotherapy
- (2018) Fernando Pastor et al. NATURE REVIEWS DRUG DISCOVERY
- Aptamer-Mediated Delivery of Splice-Switching Oligonucleotides to the Nuclei of Cancer Cells
- (2018) Jonathan W. Kotula et al. Nucleic Acid Therapeutics
- Oligonucleotide Aptamer-mediated Precision Therapy of Hematological Malignancies
- (2018) Shuanghui Yang et al. Molecular Therapy-Nucleic Acids
- An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma
- (2018) Sorah Yoon et al. Molecular Therapy-Nucleic Acids
- Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications
- (2017) Emma Hays et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- RAGE-aptamer Attenuates the Growth and Liver Metastasis of Malignant Melanoma in Nude Mice
- (2017) Nobutaka Nakamara et al. MOLECULAR MEDICINE
- First FDA Approval Agnostic of Cancer Site — When a Biomarker Defines the Indication
- (2017) Steven Lemery et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
- (2017) Xiulong Shen et al. NUCLEIC ACIDS RESEARCH
- Leptin is overexpressed in the tumor microenvironment of obese patients with estrogen receptor positive breast cancer
- (2017) Mohamed Hosney et al. Experimental and Therapeutic Medicine
- Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
- (2017) Dongxi Xiang et al. Theranostics
- Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth
- (2017) Jingying Zheng et al. Theranostics
- T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy
- (2017) Elien M. Doorduijn et al. OncoImmunology
- Selection and targeting of EpCAM protein by ssDNA aptamer
- (2017) Walhan Alshaer et al. PLoS One
- Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling
- (2016) Jasmina Paluncic et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Current Challenges in Cancer Treatment
- (2016) Jon Zugazagoitia et al. CLINICAL THERAPEUTICS
- Recent innovations in mRNA vaccines
- (2016) Jeffrey B Ulmer et al. CURRENT OPINION IN IMMUNOLOGY
- Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer
- (2016) Thomas J. Povsic et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors
- (2016) Elien M. Doorduijn et al. JOURNAL OF CLINICAL INVESTIGATION
- A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells
- (2016) Carla L. Esposito et al. JOURNAL OF CONTROLLED RELEASE
- Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo
- (2016) Sorah Yoon et al. MOLECULAR THERAPY
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies
- (2016) Y. Joy Yu Zuchero et al. NEURON
- Enhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis
- (2016) Changlin Li et al. Oncotarget
- MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells
- (2016) Mario Martínez Soldevilla et al. Oncotarget
- Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in Melanomas
- (2016) David Kryza et al. PLoS One
- Aptamer–Drug Conjugates
- (2015) Guizhi Zhu et al. BIOCONJUGATE CHEMISTRY
- Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia
- (2015) Nianxi Zhao et al. BIOMATERIALS
- Phase II study of the immune-checkpoint inhibitor ipilimumab plus dacarbazine in Japanese patients with previously untreated, unresectable or metastatic melanoma
- (2015) N. Yamazaki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer® therapeutics
- (2015) Axel Vater et al. DRUG DISCOVERY TODAY
- Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems
- (2015) Feng Jiang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial
- (2015) Michele Maio et al. JOURNAL OF CLINICAL ONCOLOGY
- Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia
- (2015) Anna Wojtuszkiewicz et al. Journal of Hematology & Oncology
- Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors
- (2015) Dongxi Xiang et al. Theranostics
- DNA aptamer raised against advanced glycation end products inhibits melanoma growth in nude mice
- (2014) Ayako Ojima et al. LABORATORY INVESTIGATION
- Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy
- (2014) B. Schrand et al. Cancer Immunology Research
- Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture
- (2013) Yanling Song et al. ANALYTICAL CHEMISTRY
- The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
- (2013) J. Hoellenriegel et al. BLOOD
- Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesisin vivo
- (2013) Vikash Reebye et al. HEPATOLOGY
- Dacarbazine in Melanoma: From a Chemotherapeutic Drug to an Immunomodulating Agent
- (2013) Selma Ugurel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation
- (2013) Sarah Shigdar et al. SENSORS
- In Vitro Selection of Modified RNA Aptamers Against CD44 Cancer Stem Cell Marker
- (2013) Nidaa Ababneh et al. Nucleic Acid Therapeutics
- CD28 Aptamers as Powerful Immune Response Modulators
- (2013) Fernando Pastor et al. Molecular Therapy-Nucleic Acids
- In vivo SELEX for Identification of Brain-penetrating Aptamers
- (2013) Congsheng Cheng et al. Molecular Therapy-Nucleic Acids
- RNA aptamers targeting cancer stem cell marker CD133
- (2012) Sarah Shigdar et al. CANCER LETTERS
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- EpCAM and its potential role in tumor-initiating cells
- (2012) Sannia Imrich et al. Cell Adhesion & Migration
- RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
- (2011) Sarah Shigdar et al. CANCER SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells
- (2011) Justin D. Lathia et al. PLoS One
- Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
- (2011) Y. J. Yu et al. Science Translational Medicine
- Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies
- (2010) Markus Münz et al. Cancer Cell International
- Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay
- (2010) Fernando Pastor et al. NATURE
- Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor
- (2010) Xin Ming et al. NUCLEIC ACIDS RESEARCH
- Molecular Assembly of an Aptamer-Drug Conjugate for Targeted Drug Delivery to Tumor Cells
- (2009) Yu-Fen Huang et al. CHEMBIOCHEM
- Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer
- (2009) Seyed Mohammad Taghdisi et al. JOURNAL OF DRUG TARGETING
- The transcriptional network for mesenchymal transformation of brain tumours
- (2009) Maria Stella Carro et al. NATURE
- Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
- (2009) Justin P Dassie et al. NATURE BIOTECHNOLOGY
- STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells
- (2009) Maureen M. Sherry et al. STEM CELLS
- Cell-Specific Aptamer Probes for Membrane Protein Elucidation in Cancer Cells
- (2008) Dihua Shangguan et al. JOURNAL OF PROTEOME RESEARCH
- Cell-Specific Internalization Study of an Aptamer from Whole Cell Selection
- (2007) Zeyu Xiao et al. CHEMISTRY-A EUROPEAN JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now